Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 26, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Molecular profiling of aggressive lymphomas.

Maura Rossi1, Maria Antonella Laginestra, Anna Gazzola

  • 1Molecular Pathology Laboratory, Haematopathology Unit, Department of Haematology and Oncology "L. and A. Seràgnoli", S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.

Advances in Hematology
|December 23, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of the PI3K/AKT/mTOR signaling pathway on trastuzumab resistance in HER2-positive gastric cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Host transcriptomic analysis reveals a defective intracellular environment that limits SARS-CoV-2 replication in CFTR-deficient airway epithelium.

Frontiers in cellular and infection microbiology·2026
Same author

Anticipating and overcoming resistance in blastic plasmacytoid dendritic cell neoplasm: new insights from pivekimab sunirine.

Haematologica·2026
Same author

From Cell Lines to Avatars: Charting the Future of Preclinical Modeling in T-Cell Malignancies.

Cells·2026
Same author

Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study.

Journal of bone oncology·2026
Same author

Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.

Lung cancer (Amsterdam, Netherlands)·2026

Molecular profiling distinguishes aggressive lymphomas like Diffuse Large B-cell Lymphoma (DLBCL) subtypes (ABC, GCB) and Burkitt Lymphoma (BL). MicroRNA analysis further refines these classifications.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Aggressive lymphomas, including Diffuse Large B-cell Lymphoma (DLBCL) and Burkitt Lymphoma (BL), are heterogeneous diseases.
  • Previous molecular profiling studies have identified distinct subtypes within DLBCL, such as the ABC and GCB subtypes, with differing clinical and pathogenetic features.
  • DLBCL and BL are recognized as distinct molecular entities, although pathological variations exist within clinical subtypes.

Purpose of the Study:

  • To review and synthesize the main concepts of molecular profiling in aggressive lymphomas.
  • To highlight recent advancements, including microRNA profiling, in distinguishing and subclassifying lymphomas like DLBCL and BL.

Main Methods:

  • Review of existing literature on molecular profiling of aggressive lymphomas.

More Related Videos

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Related Experiment Videos

Last Updated: May 26, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

  • Analysis of gene expression profiling (GEP) data to differentiate lymphoma subtypes.
  • Inclusion of microRNA profiling as a recent advancement in lymphoma subclassification.

    • Main Results:

    • Gene expression profiling (GEP) successfully differentiates DLBCL into ABC and GCB subtypes.
    • Molecular profiling confirms DLBCL and BL as distinct entities.
    • MicroRNA profiling offers additional insights for BL-DLBCL distinction and subclassification.

    Conclusions:

    • Molecular profiling is crucial for understanding the heterogeneity of aggressive lymphomas.
    • Subclassification of lymphomas like DLBCL and BL based on molecular data aids in understanding their distinct biological and clinical behaviors.
    • Continued research, including microRNA analysis, will further refine lymphoma classification and potentially guide therapeutic strategies.